Company page

Kodiak Sciences Inc

Kodiak Sciences Inc, trading under the ticker KOD, is a public company based in the United States with a market capitalization of approximately $2.26 billion. The company focuses on developing innovative therapies for eye diseases. Its commitment to advancing treatment options positions it as a key player in the biotechnology sector.